Pulmonary safety of Staccato alprazolam in healthy participants and participants with mild asthma: Phase 1, randomized, double-blind, placebo-controlled trial.
- DOI
- 10.1016/j.pupt.2026.102411
- Published
- 2026 Jun
- Container
- Pulmonary pharmacology & therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.pupt.2026.102411,
title = {Pulmonary safety of Staccato alprazolam in healthy participants and participants with mild asthma: Phase 1, randomized, double-blind, placebo-controlled trial.},
author = {Miller SD and LaForce CF and Barlow L and Watanabe S and King A and Burian M and Chanteux H},
year = {2026},
journal = {Pulmonary pharmacology \& therapeutics},
doi = {10.1016/j.pupt.2026.102411},
url = {https://doi.org/10.1016/j.pupt.2026.102411}
}RIS
TY - JOUR TI - Pulmonary safety of Staccato alprazolam in healthy participants and participants with mild asthma: Phase 1, randomized, double-blind, placebo-controlled trial. AU - Miller SD AU - LaForce CF AU - Barlow L AU - Watanabe S AU - King A AU - Burian M AU - Chanteux H PY - 2026 JO - Pulmonary pharmacology & therapeutics DO - 10.1016/j.pupt.2026.102411 UR - https://doi.org/10.1016/j.pupt.2026.102411 ER -
APA
SD, M., CF, L., L, B., S, W., A, K., M, B., & H, C. (2026). Pulmonary safety of Staccato alprazolam in healthy participants and participants with mild asthma: Phase 1, randomized, double-blind, placebo-controlled trial.. Pulmonary pharmacology & therapeutics. https://doi.org/10.1016/j.pupt.2026.102411
Source records
- pubmed · retrieved 2026-09-25T14:57:36.114Z